Industry Focus
Healthcare: Earnings Round-up -- Celgene and Gilead Sciences
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:28:55
- Mais informações
Informações:
Sinopse
How Celgene and Gilead Sciences results are fueling their stock prices this quarter, plus Merck’s Keytruda closes the sales gap between it and Bristol-Myers Squibb’s Opdivo.
